GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpoint. 1995

T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
Laboratory of Molecular Carcinogenesis, Sylvius Laboratories, Leiden University, The Netherlands.

Recently, we reported that GM1492 human diploid skin fibroblasts derived from a Bloom's patient upon UV-C irradiation fail to increase p53 to a detectable level and nevertheless accumulate in the G1-phase of the cell-cycle. Here we show that in GM1492 cells other types of DNA-damaging agents also fail to induce p53 as well as WAF1, a p53-regulated gene product involved in G1 cell-cycle arrest. Furthermore, the p53-dependent G1 cell-cycle checkpoint is indeed defective in these cells: However, induction of GADD45 mRNA still occurs in GM1492 after irradiation with UV-C. Since GADD45 is known to inhibit the entry into S, these data suggest that the observed accumulation of GM1492 cells in G1 after UV-C irradiation occurs at the G1/S boundary and is due to an inhibition of initiation of DNA-replication.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001816 Bloom Syndrome An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene (BLM) encodes a RecQ-like DNA helicase. Bloom-Torre-Machacek Syndrome,Bloom's Syndrome,Congenital Telangiectatic Erythema,Bloom Torre Machacek Syndrome,Bloom's Syndromes,Congenital Telangiectatic Erythemas,Erythema, Congenital Telangiectatic,Telangiectatic Erythema, Congenital
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097642 GADD45 Proteins Nuclear proteins that act as critical stress sensors that mediate various cellular responses, including DNA REPAIR; CELL CYCLE ARREST; and APOPTOSIS. GADD45G Protein,Gadd45 gamma Protein,Growth Arrest and DNA-Damage-Inducible 45 gamma Protein
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray

Related Publications

T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
October 1994, Cancer research,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
January 1997, The Journal of biological chemistry,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
January 1996, Biochimica et biophysica acta,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
January 1994, Mutation research,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
May 1986, Cell biology international reports,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
March 1999, Molecular and cellular biology,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
May 2000, Cancer research,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
February 2000, Radiation research,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
April 2024, Genes,
T van Laar, and W T Steegenga, and A G Jochemsen, and C Terleth, and A J van der Eb
July 1997, Oncogene,
Copied contents to your clipboard!